Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

The SMN complex.

Amelie K Gubitz1, Wenqin Feng, Gideon Dreyfuss

  • 1Department of Biochemistry and Biophysics, Howard Hughes Medical Institute, University of Pennsylvania School of Medicine, Philadelphia, PA 19104-6148, USA.

Experimental Cell Research
|May 4, 2004
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Analytical and Clinical Validation of the Plasma-Based Guardant360 CDx Test for Assessing HER2 (ERBB2) Mutation Status in Patients with Non-Small-Cell Lung Cancer for Treatment with Trastuzumab Deruxtecan in DESTINY-Lung01/02.

The Journal of molecular diagnostics : JMD·2025
Same author

RNA-binding proteins in disease etiology: fragile X syndrome and spinal muscular atrophy.

RNA (New York, N.Y.)·2024
Same author

TOMM40-APOE chimera linking Alzheimer's highest risk genes: a new pathway for mitochondria regulation and APOE4 pathogenesis.

bioRxiv : the preprint server for biology·2024
Same author

Analytical and Clinical Validation of the Oncomine Dx Target Test to Assess HER2 Mutation Status in Tumor Tissue Samples From Patients With Non-Small Cell Lung Cancer Treated With Trastuzumab Deruxtecan in the DESTINY-Lung01 and DESTINY-Lung02 Studies.

Archives of pathology & laboratory medicine·2024
Same author

Trastuzumab deruxtecan in patients with metastatic non-small-cell lung cancer (DESTINY-Lung01): primary results of the HER2-overexpressing cohorts from a single-arm, phase 2 trial.

The Lancet. Oncology·2024
Same author

Analytical and clinical validation of PATHWAY Anti-HER-2/neu (4B5) antibody to assess HER2-low status for trastuzumab deruxtecan treatment in breast cancer.

Virchows Archiv : an international journal of pathology·2023
Same journal

Early-Life Cardiovascular Programming by Maternal Protein Restriction: Electrophysiological, Structural, and Molecular Alterations in Female Rats.

Experimental cell research·2026
Same journal

The AP2α/PDHA1 signaling pathway promotes lung cancer progression by mediating aerobic glycolysis and inhibiting cuproptosis.

Experimental cell research·2026
Same journal

Distributed transcription activity in DLX proteins defies conventional mapping of a transcription activation domain.

Experimental cell research·2026
Same journal

Extracellular release of cytotoxic aggregates from HSV-1-replicating SH-SY5Y cells: involvement of alpha-synuclein and poly-ubiquitin conjugates.

Experimental cell research·2026
Same journal

MiR-1281 downregulates LMX1B to inhibit gastric cancer development.

Experimental cell research·2026
Same journal

Corrigendum to "Heat shock protein 90β stabilizes focal adhesion kinase and enhances cell migration and invasion in breast cancer cells" [Exp. Cell Res., 326, 1, 1 August 2014, Pages 78-89].

Experimental cell research·2026
See all related articles

The survival of motor neurons (SMN) protein complex is crucial for spliceosome assembly, impacting motor neuron health in spinal muscular atrophy (SMA). Understanding its function may lead to new therapeutic strategies for this neurodegenerative disease.

Area of Science:

  • Molecular Biology
  • Neuroscience
  • Genetics

Background:

  • The survival of motor neurons (SMN) protein is central to spinal muscular atrophy (SMA), a neurodegenerative disorder.
  • SMN functions within a multiprotein complex, essential for cellular processes in both cytoplasm and nuclear Gems.
  • This complex is vital for the assembly of spliceosomal small nuclear ribonucleoproteins (snRNPs).

Purpose of the Study:

  • To elucidate the role of the SMN complex in snRNP biogenesis and cellular function.
  • To explore the SMN complex's potential as an "assemblyosome" for various ribonucleoprotein (RNP) particles.
  • To identify therapeutic targets for spinal muscular atrophy by understanding SMN complex functions.

Main Methods:

  • Analysis of the SMN protein complex composition and its interaction partners.

Related Experiment Videos

  • Investigating the SMN complex's role in binding specific sequences in snRNAs.
  • Studying the SMN complex's function in the assembly of snRNPs and other RNP particles.

    • Main Results:

    • The SMN complex, containing SMN and Gemins 2-7, is essential for spliceosomal snRNP assembly.
    • SMN complex binds to snRNAs, ensuring correct RNA identity and facilitating snRNP formation.
    • The SMN complex likely acts as an assemblyosome for diverse RNP particles, potentially critical for motor neurons.

    Conclusions:

    • The SMN complex plays a fundamental role in RNA processing and RNP biogenesis.
    • Dysfunction of the SMN complex is implicated in the pathogenesis of spinal muscular atrophy.
    • Further understanding of the SMN complex's cellular roles is key to developing effective treatments for SMA.